Spravato® (Esketamine) Treatment at ShaMynds

Experience a New Path Forward

What Is SPRAVATO®?

At ShaMynds, we understand how overwhelming it can feel when depression doesn’t improve with standard treatments. That’s why we’re proud to offer Spravato® (esketamine) — an FDA-approved therapy for treatment-resistant depression and major depressive disorder with suicidal thoughts or actions.

Md Forid Uddin

Treatment-Resistant Depression (TRD): For individuals who have not achieved sufficient symptom relief despite trying at least two other antidepressant therapies.

Md Forid Uddin

Major Depressive Disorder (MDD) with Acute Suicidal Ideation or Behavior: A prompt-acting treatment option for those experiencing intense depressive episodes with immediate safety concerns.

Spravato®  works differently from traditional antidepressants. Delivered as a nasal spray in our clinic under medical supervision, it targets the NMDA receptor in the brain, helping to restore healthy activity in neural pathways linked to mood and resilience.

(A full evaluation with our provider is required to determine eligibility.)

FDA-Approved

Insurance-covered

fast-acting

What to Expect During Treatment

  • In-Clinic Care – Spravato® is only administered in a certified medical setting like ours.
  • Supervised Sessions – Our trained clinical team monitors your safety and comfort throughout.
  • Supportive Environment – We create a calming space to help you feel at ease during each visit.
  • Personalized Plan – Treatments are integrated into your overall mental health care plan for lasting progress.

We’re excited to share that Aetna, Evernorth/Cigna, and Optum Behavioral Health may cover Spravato® treatment at ShaMynds. *Coverage varies by carrier and individual plan—our team will help you verify your benefits.

4-Step SPRAVATO® Treatment Journey

Md Forid Uddin
Initial Consultation and Clinical Assessment

Begin with a no-obligation phone consultation. If initial criteria are met, our mental health professionals will conduct a full clinical review, including your treatment background. If eligible, we assist in confirming your insurance benefits with participating providers.

Md Forid Uddin
Appointment Scheduling and Treatment Sessions

Once coverage is verified, your treatment begins. Each SPRAVATO® session is administered under strict medical oversight. Patients self-administer the nasal spray while being monitored in a controlled, supportive environment for at least two hours.

Md Forid Uddin
Customized Treatment Strategy

Your treatment typically begins with twice-weekly sessions in the induction phase. This gradually transitions into a personalized maintenance schedule, based on your progress and long-term goals.

Md Forid Uddin
Ongoing Monitoring and Support

We continue to support your recovery through regular follow-ups. Adjustments to your treatment plan will be made as needed. We also maintain communication with your other healthcare providers to ensure cohesive, coordinated care.

SPRAVATO® Treatment Timeline

Md Forid Uddin
Induction

Week 1-4
2 Treatments a Week

Md Forid Uddin
maintenance

Week 5-8
1 Treatments a Week

Md Forid Uddin
ongoing care

Week 9+
Treatment frequency will be determined based on patients needs.

Why SPRAVATO® May Be More Effective Than Traditional Antidepressants

Response Rate: Traditional antidepressants typically show a response rate of 40-60%, while SPRAVATO® (esketamine) has demonstrated response rates of up to 70% in clinical trials (Popova et al., 2019, American Journal of Psychiatry).

Time to Noticeable Effect: Traditional antidepressants often take 4-6 weeks for noticeable improvements, whereas patients using SPRAVATO® (esketamine) may experience relief within 24 hours, as observed in clinical trials (BMC Psychiatry, 2022).

Sustained Remission Rate: Traditional antidepressants achieve sustained remission rates of approximately 15-30%, but SPRAVATO® has shown remission rates as high as 80% when combined with an oral antidepressant (Wilkinson et al., 2018, Nature Reviews Drug Discovery).

Response Rate

Md Forid Uddin

Time to Noticeable Effect

Md Forid Uddin

Sustained Remission Rate

Md Forid Uddin

Our Philosophy

Asset 19

Prioritizing Safety

We follow FDA guidance and use only approved therapies. While some clinics may use off-label ketamine, we focus exclusively on treatments backed by clinical research.

Asset 20

The Environment Matters

Healing is influenced by surroundings. Our clinic is designed with calming, thoughtful aesthetics to support your well-being throughout treatment.

Asset 21

Collaborative Care

If you’re already working with a therapist or psychiatrist, we ensure full coordination so all aspects of your care work in harmony.

Asset 22

Simplified Access

We work with your insurance and handle all necessary paperwork.

What Our Patients Are Saying

Transformative Experiences

Transformation: What People Who Finally Found Relief With SPRAVATO® Have to Say

Explore the inspiring journeys of individuals who have transformed their lives through the clinical use of SPRAVATO®. From overcoming obstacles to reaching significant milestones, these individuals share how SPRAVATO® treatment has been instrumental in reshaping their habits and creating lasting change. Discover real-life stories of success, motivation, and the powerful impact of building sustainable habits for a better life.

If you’ve been searching for hope beyond traditional medications, Spravato® may be the breakthrough you’ve been waiting for.

SPRAVATO® FAQs

Inform your healthcare provider about your medical history, current medications, allergies, and any conditions like high blood pressure or heart issues.
SPRAVATO® is a nasal spray formulation of esketamine, administered under supervision, while IV ketamine is an intravenous treatment, with differences in delivery and medical oversight.
No, SPRAVATO® must be taken under a healthcare provider’s supervision due to its potential side effects and risks.
You should not take SPRAVATO® during pregnancy or breastfeeding unless advised by your provider, as it may pose risks to the baby.
People with certain conditions like uncontrolled high blood pressure, aneurysms, or a history of psychosis should not use SPRAVATO® unless cleared by a provider.
Your healthcare provider will monitor your symptoms and response over time to determine if the treatment is effective.
Contact your healthcare provider for guidance on rescheduling or adjusting your treatment plan if you miss a dose.
Yes, inform all your healthcare providers about your SPRAVATO® use to avoid interactions with other treatments.
If you don’t respond, your provider may adjust your treatment or explore alternative options.
SPRAVATO® may not be suitable if your blood pressure is uncontrolled; consult your provider.
Yes, it can interact with certain medications, so inform your provider about everything you’re taking.
You must avoid liquids for 30 minutes before your treatment and food must be avoided for 2 hours before each treatment.

Avoid driving until the following day after a good night’s rest.

No, you should not drive for at least 24 hours after treatment due to potential sedation and side effects.

SPRAVATO® Resources

Download our comprehensive PDF guides to learn about SPRAVATO®, its benefits, uses, and other important safety information.

Take the First Step Today

Your Path to Wellness Begins Here

Don’t let mental health challenges or uncertainty hold you back from living the life you deserve. At ShaMynds, we’re here to provide you with compassionate care, advanced treatments, and unwavering support every step of the way. Whether you’re ready to start a new chapter or simply want to explore your options, we’re here to guide you.

Take that first step toward balance and well-being today.

Contact Us